SeHCAT

SeHCAT (23-seleno-25-homo-tauro-cholic acid) is a radiopharmaceutical used in the investigation of bile salt malabsorption, which is a cause of chronic diarrhoea. 

Characteristics

  • physical half-life: 118 days

Uses, dosage and timings

A capsule containing SeHCAT is ingested with water. The patient is scanned using a gamma camera 2-3 hours after ingesting the capsule. The patient is rescanned after 7 days and the percentage of retention is calculated.

More than 15% retention is normal and mitigates against a diagnosis of bile salt malabsorption. 

Share article

Article information

rID: 39306
Section: Physics
Synonyms or Alternate Spellings:
  • 23-seleno-25-homo-tauro-cholic acid

Support Radiopaedia and see fewer ads

Updating… Please wait.
Loadinganimation

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.